Syndrome of anosmia with hypogonadotropic hypogonadism (Kallmann syndrome): clinical and laboratory studies in 23 cases.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006062:Gonadotropins / Q000172:deficiency*; D006801:Humans; D007006:Hypogonadism / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D007986:Luteinizing Hormone / Q000096:biosynthesis; D008297:Male; D008875:Middle Aged; D000857:Olfaction Disorders / Q000150:complications* / Q000235:genetics; D010053:Ovary / Q000254:growth & development; D010641:Phenotype; D011388:Prolactin / Q000097:blood; D013091:Spermatogenesis / Q000187:drug effects; D013577:Syndrome; D013737:Testis / Q000473:pathology
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D002996:Clomiphene; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone